BioSpace News Archive

TIGLUTIK, the First and Only Easy-to-Swallow Thickened Riluzole Liquid for ALS, will be Commercially Available Mid-October of 2018

Allogene Therapeutics, Inc. today announced it has completed a $120 million private financing of Convertible Notes.

The Canadian Medical Association (CMA), in partnership with the CMA Foundation, is thrilled to announce the 14 recipients of the inaugural Healthy Canadians Grants, a program designed to support grassroots health-related initiatives across the country.

Avanos Medical, Inc. (NYSE: AVNS) today announced that Steve Voskuil, chief financial officer, will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt hotel in New York on Thursday, Sept. 13 at approximately 10:35 a.m., ET.

Three issued U.S. patents add to existing protection for clinical drug candidates derived from Protagonist’s innovative peptide technology platform

Nearly 100 percent of chief medical information officers (CMIOs) in U.S. hospitals believe medication management improvement initiatives are having a positive impact and that patient safety issues are less likely to occur today, as compared to 5 years ago, according to a new survey from the Association of Medical Directors of Information Systems (AMDIS)

Recognition underscores company’s commitment to providing comprehensive pharmacy benefit information to CVS Caremark members

U.S. CEOs more likely to say they are achieving return on investment than global peers

Leading Neuroblastoma Cancer Foundation to Raise Funds to Support Research and Immunotherapy Treatment for Young Patients

Studies Underscore Company’s Ongoing Commitment to Working Collaboratively on Meaningful Solutions to Address the Opioid Crisis.